Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

Clinical trial NCT05317858 · RECRUITING

Trial details

NCT number: NCT05317858
Sponsor: InSightec
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Brain Tumor Non Small Cell Lung Cancer

Start date: 2022-08-12
Primary completion: 2027-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.